JOHNSON & JOHNSON

NEW BRUNSWICK, NJ · CIK 200406 · 13F filing filed 2026-08-06

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

Legal entityJohnson & Johnson (US)

Other 13F filers in this group: Johnson & Johnson Innovation - JJDC, Inc. files a notice

Others nearbyNew Brunswick, NJ, Slough, Leeds
FamilyJOHNSON & JOHNSON · 2 related pages

As an employer

UK employer size1000 to 4999

Where they work

people there (dot area)number not reportedHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

In the UK

3 UK companies in the group; those with staff figures, a pay gap report, FCA authorisation or fund management as their business are listed.

Company	Town	Staff	Pay gap report	FCA register
DEPUY INTERNATIONAL LIMITED Private Limited Company	Leeds West Yorkshire		250 to 499
JANSSEN-CILAG LIMITED Private Limited Company	Maidenhead		1000 to 4999

Gender pay gap report	Size	Hourly gap	Bonus gap	Women in top quarter of pay
DEPUY INTERNATIONAL LIMITED2025	250 to 499	9.4%	5.0%	45%
JANSSEN-CILAG LIMITED2025	1000 to 4999	10.0%	27.4%	51%

Sources: Companies House (accounts filed electronically; the largest groups often file on paper, so their staff numbers can be missing), the UK gender pay gap service (employers with 250+ staff) and the FCA's Financial Services Register. Contains public sector information licensed under the Open Government Licence v3.0.

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$798.7m reported value +22.4% vs Q1 2026

15positions

98.4%in top 10

1 new 0 added 0 reduced 2 sold out vs Q1 2026

This report includes the holdings of 1 other manager that shares the investment decisions:

Johnson & Johnson Innovation - JJDC, Inc. – reports through this filing

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change
1	PROTAGONIST THERAPEUTICS INC COM PTGX	PTGX	2,449,183	$300.2m37.59%	37.59%	Unchanged
2	NANOBIOTIX SPONSORED ADS NBTX	NBTX	5,623,816	$212.0m26.55%	26.55%	Unchanged
3	MEIRAGTX HLDGS PLC COM MGTX	MGTX	6,641,064	$89.7m11.23%	11.23%	Unchanged
4	RAPPORT THERAPEUTICS INC COM RAPP	RAPP	1,784,517	$74.4m9.31%	9.31%	Unchanged
5	CONTINEUM THERAPEUTICS INC CL A CTNM	CTNM	1,979,173	$32.4m4.06%	4.06%	Unchanged
6	LEGEND BIOTECH CORP SPONSORED ADS LEGN	LEGN	814,586	$23.5m2.95%	2.95%	Unchanged
7	CVRX INC COM CVRX	CVRX	4,024,861	$20.7m2.59%	2.59%	Unchanged
8	XENCOR INC COM XNCR	XNCR	748,062	$12.0m1.51%	1.51%	Unchanged
9	CEREBRAS SYSTEMS INC COM CL A CBRS	CBRS	53,586	$11.8m1.48%	1.48%	New
10	FATE THERAPEUTICS INC COM FATE	FATE	3,379,064	$9.1m1.14%	1.14%	Unchanged
11	PROCEPT BIOROBOTICS CORP COM PRCT	PRCT	357,939	$8.1m1.01%	1.01%	Unchanged
12	NEUMORA THERAPEUTICS INC. COM NMRA	NMRA	1,849,445	$3.1m0.39%	0.39%	Unchanged
13	VOR BIOPHARMA INC COM NEW VOR	VOR	53,732	$989.2k0.12%	0.12%	Unchanged
14	STANDARD BIOTOOLS INC COM LAB	LAB	311,967	$256.7k0.03%	0.03%	Unchanged
15	ADICET BIO INC COM NEW ACET	ACET	22,779	$196.8k0.02%	0.02%	Unchanged

Sold out since Q1 2026

Security	Ticker	Shares held before	Value then
RALLYBIO CORP RLYB	RLYB	152,901	$1.4m152.9k shares
NANO X IMAGING LTD NNOX	NNOX	83,554	$189.7k83.6k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

Company	Ticker	Stake	Change	Schedule	Last filed
CVRX INC CVRX · 13G · filed 2026-01-12	CVRX	15.4%≈ $20.7m		13G	2026-01-12